Clinical Trial Update: Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

An early-stage clinical trial is investigating autologous bone marrow mesenchymal stem cell therapy for ischemic stroke; the study is currently not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Autologous bone marrow mesenchymal stem cell therapy (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: Ischemic Stroke | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING